Support Alert

Class 3 Medicines Recall: Accord Healthcare Limited, Irinotecan Hydrochloride Concentrate for Solution for Infusion 20mg/ml (5ml vial) EL (20)A/33

Accord Healthcare Limited has informed MHRA it is recalling a batch as a precautionary measure, due to the observation of precipitation in the solution in the same batch marketed in another country (Malta). No complaints or adverse reaction reports have been received by the company to date for the UK product.

Further information, including the affected batch and advice for health professionals is available on the MHRA website

 

Loading...

Renew for 2022

Your dedication to patient care has made us proud during 2021.

That's why you can count on us to represent your interests and support your efforts every step of the way in 2022.

RENEW YOUR MEMBERSHIP TODAY